Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.
Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Allen-Mersh TG, et al. Among authors: fordy c. Lancet. 1994 Nov 5;344(8932):1255-60. doi: 10.1016/s0140-6736(94)90750-1. Lancet. 1994. PMID: 7526096 Clinical Trial.
Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases.
Durand-Zaleski I, Earlam S, Fordy C, Davies M, Allen-Mersh TG. Durand-Zaleski I, et al. Among authors: fordy c. Cancer. 1998 Sep 1;83(5):882-8. Cancer. 1998. PMID: 9731890
Hepatic arterial floxuridine as second-line treatment for systemic fluorouracil-resistant colorectal liver metastases.
Fordy C, Glover C, Davies MM, Allen-Mersh TG. Fordy C, et al. Br J Cancer. 1998 Oct;78(8):1058-60. doi: 10.1038/bjc.1998.627. Br J Cancer. 1998. PMID: 9792150 Free PMC article. Clinical Trial.
Randomized trial of regional plus systemic fluorinated pyrimidine compared with systemic fluorinated pyrimidine in treatment of colorectal liver metastases.
Allen-Mersh TG, Glover C, Fordy C, Mathur P, Quinn H. Allen-Mersh TG, et al. Among authors: fordy c. Eur J Surg Oncol. 2000 Aug;26(5):468-73. doi: 10.1053/ejso.1999.0924. Eur J Surg Oncol. 2000. PMID: 11016468 Clinical Trial.
Contribution of diet, tumour volume and patient-related factors to weight loss in patients with colorectal liver metastases.
Fordy C, Glover C, Henderson DC, Summerbell C, Wharton R, Allen-Mersh TG. Fordy C, et al. Br J Surg. 1999 May;86(5):639-44. doi: 10.1046/j.1365-2168.1999.01086.x. Br J Surg. 1999. PMID: 10361185
Relation between depression and circulating immune products in patients with advanced colorectal cancer.
Allen-Mersh TG, Glover C, Fordy C, Henderson DC, Davies M. Allen-Mersh TG, et al. Among authors: fordy c. J R Soc Med. 1998 Aug;91(8):408-13. doi: 10.1177/014107689809100803. J R Soc Med. 1998. PMID: 9816354 Free PMC article.
Management of symptomatic locoregional recurrence during regional chemotherapy for colorectal liver metastases.
Davies MM, Fordy C, Burke D, Allen-Mersh TG. Davies MM, et al. Among authors: fordy c. Br J Surg. 1998 Mar;85(3):364-6. doi: 10.1046/j.1365-2168.1998.00592.x. Br J Surg. 1998. PMID: 9529494
Effect of regional and systemic fluorinated pyrimidine chemotherapy on quality of life in colorectal liver metastasis patients.
Earlam S, Glover C, Davies M, Fordy C, Allen-Mersh TG. Earlam S, et al. Among authors: fordy c. J Clin Oncol. 1997 May;15(5):2022-9. doi: 10.1200/JCO.1997.15.5.2022. J Clin Oncol. 1997. PMID: 9164214 Clinical Trial.
Hepatic arterial cannulation for regional chemotherapy is safe in patients with a liver metastasis volume of less than 1 litre.
Burke D, Fordy C, Earlam SA, Allen-Mersh TG. Burke D, et al. Among authors: fordy c. Br J Cancer. 1997;75(8):1213-6. doi: 10.1038/bjc.1997.207. Br J Cancer. 1997. PMID: 9099972 Free PMC article.
Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma by reverse transcriptase polymerase chain reaction.
Jonas S, Windeatt S, O-Boateng A, Fordy C, Allen-Mersh TG. Jonas S, et al. Among authors: fordy c. Gut. 1996 Nov;39(5):717-21. doi: 10.1136/gut.39.5.717. Gut. 1996. PMID: 9014772 Free PMC article.
15 results
Jump to page
Feedback